Former AstraZeneca Personalized Healthcare Strategy Leader Named Senior Vice President of Companion Diagnostics at DiaCarta

by Claudia Li | May 13, 2021 | Press Releases

Press release Home ❯News & Events❯Press Releases❯ You are here ❯ Home ❯ Month ❯ May ❯ Former AstraZeneca Personalized Healthcare Strategy Leader Named Senior Vice President of Companion Diagnostics at DiaCarta FollowFollow Richmond, California, May 13, 2021. DiaCarta...

DiaCarta’s Novel XNA Technology Rapidly Detects Raging New SARS-CoV-2 Variants

by Claudia Li | Apr 22, 2021 | Press Releases

Press release Home ❯News & Events❯Press Releases❯ You are here ❯ Home ❯ Month ❯ April ❯ DiaCarta’s Novel XNA Technology Rapidly Detects Raging New SARS-CoV-2 Variants FollowFollow Richmond, California, April 22, 2021. DiaCarta Inc., a precision molecular...

DiaCarta Announces Publication in Nature Scientific Reports Demonstrating cfDNA Biomarker Algorithm Predicts Response and Outcome of Chemotherapy

by Claudia Li | Apr 8, 2021 | Press Releases

Press release Home ❯News & Events❯Press Releases❯ You are here ❯ Home ❯ Search ❯ Breast Cancer Panel ❯ DiaCarta Announces Publication in Nature Scientific Reports Demonstrating cfDNA Biomarker Algorithm Predicts Response and Outcome of Chemotherapy FollowFollow...

Kinetics of Plasma cfDNA Predicts Clinical Response in Non‑Small Cell Lung Cancer Patients

by Claudia Li | Apr 7, 2021 | Publications

A high-throughput Anti-SARS-CoV-2 IgG testing platform for COVID-19

by Claudia Li | Nov 13, 2020 | Publications